Your email has been successfully added to our mailing list.

×
-0.000103092783505061 -0.000103092783505061 -0.0041237113402061 -0.00329896907216488 -0.00319587628865982 -0.000103092783505061 -0.011340206185567 0
Stock impact report

Glaukos reports preliminary Q4 results [Seeking Alpha]

Glaukos Corporation (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
The company reaffirms its 2026 net sales guidance range of $600 million to $620 million. More on Glaukos Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth Glaukos Q3 2025 Earnings Preview Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GKOS alerts
Opt-in for
GKOS alerts

from News Quantified
Opt-in for
GKOS alerts

from News Quantified